Relmada Therapeutics(RLMD) - 2024 Q4 - Earnings Call Transcript
Relmada Therapeutics(RLMD)2025-03-28 00:07Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Brian Ritchie - LifeSci Advisors, IR Sergio Traversa - CEO Maged Shenouda - CFO Conference Call Participants Uy Ear - Mizuho Securities Andrew Tsai - Jefferies Operator Greetings, and welcome to the Relmada Therapeutics, Incorporated Quarter 4 2024 Financial Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal present ...